San Diego
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
321- Dermatology
- 241
- Plastic Surgery
- 80
Medspa accounts need a supervising physician's NPI
Because ordering is limited to licensed clinics, physicians and physician-supervised practices, a medspa setting up an account provides the NPI of its supervising or medical director physician rather than a general business registration. Most medspas already structure other physician-only vendor relationships the same way.
Documentation dermatology and aesthetic buyers typically request
Before a Wharton's jelly or exosome product is added to an approved vendor list, dermatology and aesthetic practices commonly ask for the certificate of analysis, donor eligibility summary and lot release record, and for the full ingredient disclosure on lyophilized exosome products. None of this substitutes for the practice's own regulatory review of its specific intended use.
- Certificate of analysis per lot
- Donor eligibility summary
- Lot release record
- Full ingredient disclosure for lyophilized exosome products
Shipping to San Diego: cold-chain and shelf-stable formats
Cryopreserved Wharton's jelly formats ship overnight on dry ice in validated containers for direct transfer to -80 degree C storage, logged against the lot number at receiving. The lyophilized Wharton's jelly format and the lyophilized exosome products are shelf-stable and are stored and reconstituted according to the insert supplied with each lot.
Confirming regulatory standing before you order
A medspa's medical director should confirm the practice's standing with the California medical board and review any specific intended use with counsel before incorporating a Wharton's jelly or exosome product into the practice.
FDA has stated there are no FDA-approved exosome products, and they are generally regulated as biologic drugs; that regulatory posture, and whether a Wharton's jelly product's intended use qualifies under 21 CFR 1271.10, are determinations for the physician and counsel, not the distributor. These products are not FDA approved or licensed for any disease or condition; information here is for licensed healthcare professionals and is not medical or legal advice.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Does a San Diego medspa need its own NPI to order, or can it use the medical director's?+
An account is tied to a verified NPI for a licensed physician, which for most medspas is the supervising or medical director physician rather than the business entity.
Are Wharton's jelly and exosome products regulated the same way?+
No. Wharton's jelly products are supplied under the supplier's HCT/P framework, while exosome products are not FDA approved and are generally regulated as biologic drugs under section 351 of the PHS Act. Both determinations about specific use sit with the physician and counsel.
Is pricing published for San Diego accounts?+
No. Pricing is available to verified accounts rather than published on this site.